HPV-risico

Qualitative detection of 14 high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68) as well as putative HPV high risk type 67, with separate identification of HPV16 and 18 in one test.Fully clinically validated HPV screening method to identify women at risk for cervical (pre) cancer using either cervical scrape or self-collected vaginal sample.Special Features:Design based on E7 targetregion:Overcomes potential false-negative results caused by viral DNA integration during cancer developmentHPV types detected:14 hrHPV types: HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68 as well as putative HPV high risk type 67Fully clinically validated:Compliance to International Screening Guidelines for HPV DNA tests1,2,3Flexible:Suitable for different sample types including self-collected samplesCompatible with common DNA extraction methodsReliable:Build-in check for sample quality ensuring reliable resultsEasy:Limited hands-on time due to the ready-to-use master mixHPV-Risk assay is a registered trademark of the legal manufacturer, Self-screen B.V., the Netherlands, and is distributed by Fujirebio Europe.